CSIMarket
 
Propanc Biopharma Inc   (PPCH)
Other Ticker:  
 
 
Price: $0.0000 $0.00 %
Day's High: 0.00 Week Perf:
Day's Low: $ 0.00 30 Day Perf:
Volume (M): 0 52 Wk High: $ 0.00
Volume (M$): $ 0 52 Wk Avg: $0.00
Open: $0.00 52 Wk Low: $0.00



 Market Capitalization (Millions $) -
 Shares Outstanding (Millions) 24
 Employees -
 Revenues (TTM) (Millions $) -
 Net Income (TTM) (Millions $) -2
 Cash Flow (TTM) (Millions $) 0
 Capital Exp. (TTM) (Millions $) 0

Propanc Biopharma Inc
Propanc Biopharma Inc is a clinical-stage biopharmaceutical company that develops and commercializes treatment options for patients suffering from pancreatic cancer and various gastrointestinal cancers. The company focuses on developing proprietary formulations of proenzymes, which are inactive forms of enzymes, to activate enzymes that can target and destroy cancer cells. These proenzymes aim to improve the efficacy and safety of existing cancer treatments and have the potential to become a major advancement in cancer therapy. Propanc Biopharma is committed to conducting preclinical and clinical trials to develop its lead product, PRP, with the goal of gaining regulatory approval and bringing it to market.


   Company Address: 302 Camberwell, VIC 3124
   Company Phone Number: 9882 0780   Stock Exchange / Ticker: PPCH
   


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Propanc Biopharma Inc

Propanc Biopharma Inc Shocks Investors with Operating Shortfall in Q2 of 2024

Investors were caught off guard by unexpected modifications at PPCH during the recent earnings season, with the company reporting an operating shortfall of $-0.438064 million for the October to December 31, 2023 period. This figure represents a significant increase from the previous year's operating shortfall.
Despite the disappointing financial results, the company's management has made key decisions to improve day-to-day operations, surpassing previous performance in this area. PPCH is focusing on its progress cycle, which is expected to drive future growth and profitability.






 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com